A Personal Cancer Vaccine (NEO-PV-01) With Pembrolizumab and Chemotherapy for Patients With Lung Cancer

Clinical trial NCT03380871 · COMPLETED

Trial details

NCT number: NCT03380871
Sponsor: BioNTech US Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung Lung Cancer Nonsquamous Nonsmall Cell Neoplasm of Lung

Start date: 2018-05-04
Primary completion: 2019-10-31
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.